Kaplon H, Chenoweth A, Crescioli S, Reichert JM. Antibodies to watch in 2022. mAbs. 2022;14(1):2014296.

Kaplon H, Crescioli S, Chenoweth A, Visweswaraiah J, Reichert JM. Antibodies to watch in 2023. mAbs. 2023;15(1):2153410.

Fu Z, Li S, Han S, Shi C, Zhang Y. Antibody drug conjugate: the “biological missile” for targeted cancer therapy. Signal Transduct Target Ther. 2022;7(1):93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joubert N, Beck A, Dumontet C, Denevault-Sabourin C. Antibody-drug conjugates: the last decade. Pharmaceuticals (Basel). 2020;13(9):245.

Nadkarni DV. Conjugations to endogenous cysteine residues. Methods Mol Biol (Clifton, NJ). 2020;2078:37–49.

Article  CAS  Google Scholar 

Haque M, Forte N, Baker JR. Site-selective lysine conjugation methods and applications towards antibody-drug conjugates. Chem Commun (Camb). 2021;57(82):10689–702.

Article  CAS  PubMed  Google Scholar 

Sadiki A, Vaidya SR, Abdollahi M, Bhardwaj G, Dolan ME, Turna H, et al. Site-specific conjugation of native antibody. Antib Ther. 2020;3(4):271–84.

CAS  PubMed  PubMed Central  Google Scholar 

Adhikari P, Zacharias N, Ohri R, Sadowsky J. Site-specific conjugation to Cys-engineered THIOMAB™ antibodies. Methods Mol Biol (Clifton, NJ). 2020;2078:51–69.

Article  CAS  Google Scholar 

Hallam TJ, Wold E, Wahl A, Smider VV. Antibody conjugates with unnatural amino acids. Mol Pharm. 2015;12(6):1848–62.

Article  CAS  PubMed  Google Scholar 

Diamantis N, Banerji U. Antibody-drug conjugates–an emerging class of cancer treatment. Br J Cancer. 2016;114(4):362–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu Y, Wang D, Mason B, Rossomando T, Li N, Liu D, et al. Structure, heterogeneity and developability assessment of therapeutic antibodies. mAbs. 2019;11(2):239–64.

Beck A, D’Atri V, Ehkirch A, Fekete S, Hernandez-Alba O, Gahoual R, et al. Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future. Expert Rev Proteomics. 2019;16(4):337–62.

Article  CAS  PubMed  Google Scholar 

Deslignière E, Diemer H, Erb S, Coliat P, Pivot X, Detappe A, et al. A combination of native LC-MS approaches for the comprehensive characterization of the antibody-drug conjugate trastuzumab deruxtecan. Front Biosci (Landmark Ed). 2022;27(10):290.

Article  PubMed  Google Scholar 

van Schaick G, Haselberg R, Somsen GW, Wuhrer M, Domínguez-Vega E. Studying protein structure and function by native separation-mass spectrometry. Nat Rev Chem. 2022;6(3):215–31.

Article  PubMed  Google Scholar 

Donnelly DP, Rawlins CM, DeHart CJ, Fornelli L, Schachner LF, Lin Z, et al. Best practices and benchmarks for intact protein analysis for top-down mass spectrometry. Nat Methods. 2019;16(7):587–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brodbelt JS. Deciphering combinatorial post-translational modifications by top-down mass spectrometry. Curr Opin Chem Biol. 2022;70: 102180.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chapman EA, Aballo TJ, Melby JA, Zhou T, Price SJ, Rossler KJ, et al. Defining the sarcomeric proteoform landscape in ischemic cardiomyopathy by top-down proteomics. J Proteome Res. 2023;22(3):931–41.

Article  CAS  PubMed  Google Scholar 

Jeanne Dit Fouque K, Miller SA, Pham K, Bhanu NV, Cintron-Diaz YL, Leyva D, et al. Top-“double-down” mass spectrometry of histone H4 proteoforms: tandem ultraviolet-photon and mobility/mass-selected electron capture dissociations. Anal Chem. 2022;94(44):15377–85.

Lodge JM, Schauer KL, Brademan DR, Riley NM, Shishkova E, Westphall MS, et al. Top-down characterization of an intact monoclonal antibody using activated ion electron transfer dissociation. Anal Chem. 2020;92(15):10246–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin Y, Lin Z, Xu Q, Fu C, Zhang Z, Zhang Q, et al. Comprehensive characterization of monoclonal antibody by Fourier transform ion cyclotron resonance mass spectrometry. mAbs. 2019;11(1):106–15.

He L, Anderson LC, Barnidge DR, Murray DL, Hendrickson CL, Marshall AG. Analysis of monoclonal antibodies in human serum as a model for clinical monoclonal gammopathy by use of 21 Tesla FT-ICR top-down and middle-down MS/MS. J Am Soc Mass Spectrom. 2017;28(5):827–38.

Article  CAS  PubMed  Google Scholar 

van der Burgt YEM, Kilgour DPA, Tsybin YO, Srzentić K, Fornelli L, Beck A, et al. Structural analysis of monoclonal antibodies by ultrahigh resolution MALDI in-source decay FT-ICR mass spectrometry. Anal Chem. 2019;91(3):2079–85.

Article  PubMed  Google Scholar 

Shaw JB, Liu W, Vasil Ev YV, Bracken CC, Malhan N, Guthals A, et al. Direct determination of antibody chain pairing by top-down and middle-down mass spectrometry using electron capture dissociation and ultraviolet photodissociation. Anal Chem. 2020;92(1):766–73.

Article  CAS  PubMed  Google Scholar 

Kellie JF, Schneck NA, Causon JC, Baba T, Mehl JT, Pohl KI. Top-down characterization and intact mass quantitation of a monoclonal antibody drug from serum by use of a quadrupole TOF MS system equipped with electron-activated dissociation. J Am Soc Mass Spectrom. 2023;34(1):17–26.

Article  CAS  PubMed  Google Scholar 

Watts E, Williams JD, Miesbauer LJ, Bruncko M, Brodbelt JS. Comprehensive middle-down mass spectrometry characterization of an antibody-drug conjugate by combined ion activation methods. Anal Chem. 2020;92(14):9790–8.

Article  CAS  PubMed  Google Scholar 

Larson EJ, Roberts DS, Melby JA, Buck KM, Zhu Y, Zhou S, et al. High-throughput multi-attribute analysis of antibody-drug conjugates enabled by trapped ion mobility spectrometry and top-down mass spectrometry. Anal Chem. 2021;93(29):10013–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen B, Lin Z, Zhu Y, Jin Y, Larson E, Xu Q, et al. Middle-down multi-attribute analysis of antibody-drug conjugates with electron transfer dissociation. Anal Chem. 2019;91(18):11661–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hernandez-Alba O, Houel S, Hessmann S, Erb S, Rabuka D, Huguet R, et al. A case study to identify the drug conjugation site of a site-specific antibody-drug-conjugate using middle-down mass spectrometry. J Am Soc Mass Spectrom. 2019;30(11):2419–29.

Article  CAS  PubMed  Google Scholar 

Sang H, Lu G, Liu Y, Hu Q, Xing W, Cui D, et al. Conjugation site analysis of antibody-drug-conjugates (ADCs) by signature ion fingerprinting and normalized area quantitation approach using nano-liquid chromatography coupled to high resolution mass spectrometry. Anal Chim Acta. 2017;955:67–78.

Article  CAS  PubMed  Google Scholar 

Bashyal A, Dunham SD, Brodbelt JS. Characterization of unbranched ubiquitin tetramers by combining ultraviolet photodissociation with proton transfer charge reduction reactions. Anal Chem. 2023;95(37):14001–8.

Article  CAS  PubMed  Google Scholar 

Walker JN, Lam R, Brodbelt JS. Enhanced characterization of histones using 193 nm ultraviolet photodissociation and proton transfer charge reduction. Anal Chem. 2023;95(14):5985–93.

Article  CAS  PubMed  Google Scholar 

Huguet R, Mullen C, Srzentić K, Greer JB, Fellers RT, Zabrouskov V, et al. Proton transfer charge reduction enables high-throughput top-down analysis of large proteoforms. Anal Chem. 2019;91(24):15732–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunham SD, Wei B, Lantz C, Loo JA, Brodbelt JS. Impact of internal fragments on top-down analysis of intact proteins by 193 nm UVPD. J Proteome Res. 2023;22(1):170–81.

Article  CAS  PubMed  Google Scholar 

Kline JT, Mullen C, Durbin KR, Oates RN, Huguet R, Syka JEP, et al. Sequential ion-ion reactions for enhanced gas-phase sequencing of large intact proteins in a tribrid Orbitrap mass spectrometer. J Am Soc Mass Spectrom. 2021;32(9):2334–45.

Article  CAS  PubMed  Google Scholar 

Lantz C, Zenaidee MA, Wei B, Hemminger Z, Ogorzalek Loo RR, Loo JA. ClipsMS: an algorithm for analyzing internal fragments resulting from top-down mass spectrometry. J Proteome Res. 2021;20(4):1928–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schmitt ND, Berger JM, Conway JB, Agar JN. Increasing top-down mass spectrometry sequence coverage by an order of magnitude through optimized internal fragment generation and assignment. Anal Chem. 2021;93(16):6355–62.

Article  CAS  PubMed  Google Scholar 

Stephenson JL Jr, McLuckey SA. Simplification of product ion spectra derived from multiply charged parent ions via ion/ion chemistry. Anal Chem. 1998;70(17):3533–44.

Article  CAS  PubMed  Google Scholar 

Rolfs Z, Smith LM. Internal fragment ions disambiguate and increase identifications in top-down proteomics. J Proteome Res. 2021;20(12):5412–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei B, Lantz C, Liu W, Viner R, Ogorzalek Loo RR, Campuzano IDG, et al. Added value of internal fragments for top-down mass spectrometry of intact monoclonal antibodies and antibody-drug conjugates. Anal Chem. 2023;95(24):9347–56.

Article  CAS  PubMed  Google Scholar 

Lyon YA, Riggs D, Fornelli L, Compton PD, Julian RR. The ups and downs of repeated cleavage and internal fragment production in top-down proteomics. J Am Soc Mass S